The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010
Harvey A Whiteford, Alize J Ferrari, Louisa Degenhardt, Valery Feigin, Theo Vos, Harvey A Whiteford, Alize J Ferrari, Louisa Degenhardt, Valery Feigin, Theo Vos
Abstract
Background: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders.
Method: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs.
Results: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific.
Conclusion: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223. 10.1016/S0140-6736(12)61689-4
- World Health Organization (2008) The global burden of disease: 2004 update. Geneva: World Health Organization.
- Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, et al. (2007) Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. The Lancet 370: 841–850.
- Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, et al. (2007) Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6: 177–185.
- Jorm AF (2012) Mental health literacy: empowering the community to take action for better mental health. Am Psychol 67: 231–243. 10.1037/a0025957
- Cheng AT (2001) Case definition and culture: Are people all the same? Br J Psychiatry 179: 1–3.
- Yang LH, Link BG (2009) Comparing diagnostic methods for mental disorders in China. Lancet 373: 2002–2004. 10.1016/S0140-6736(09)61091-6
- Whiteford1 HA, Ferrari AJ, Baxter AJ, Charlson FJ, Degenhardt L (2013) How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010? Current Opinion in Psychiatry 26: 376–383. 10.1097/YCO.0b013e328361e60f
- Murray CJL, Lopez AD, editors (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press;
- Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, et al. (2012) Age-specifi c and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2071–2094. 10.1016/S0140-6736(12)61719-X
- Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163–2196. 10.1016/S0140-6736(12)61729-2
- Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, et al. (2012) Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 380: 2144–2162. 10.1016/S0140-6736(12)61690-0
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128. 10.1016/S0140-6736(12)61728-0
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224–2260. 10.1016/S0140-6736(12)61766-8
- Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, et al. (2013) The Global Burden of Mental and Substance Use Disorders, 2010. The Lancet 382: 1575–1586. 10.1016/S0140-6736(13)61611-6
- Baxter AJ, Patton G, Degenhardt L, Scott KM, Whiteford HA (2013) Global epidemiology of mental disorders: what are we missing?. PLOS One 8 10.1371/journal.pone.0082806
- Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, et al. (2014) The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend 137: 37–47.
- Degenhardt L, Bucello C, Calabria B, Nelson P, Roberts A, et al. (2011) What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 117: 85–101. 10.1016/j.drugalcdep.2010.11.032
- Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, et al. (2014) The global epidemiology and burden of opioid dependence: Results from the Global Burden of Disease 2010 study. Addiction 109: 1320–1333. 10.1111/add.12551
- Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, et al. (2013) The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLOS One 8: e76635 10.1371/journal.pone.0076635
- Ferrari AJ, Baxter AJ, Whiteford HA (2010) A systematic review of the global distribution and availability of prevalence data for bipolar disorder. Journal of Affective Disorders 34: 1–13.
- Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Murray CJL, et al. (2013) Burden of depressive disorders by country, sex, age and year: Findings from the Global Burden of Disease Study 2010. PLOS Medicine 10: e1001547 10.1371/journal.pmed.1001547
- Erskine HE, Ferrari AJ, Polanczyk GV, Moffitt TE, Murray CJ, et al. (2014) The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. Journal of Child Psychology and Psychiatry 55: 328–336. 10.1111/jcpp.12186
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington DC: American Psychiatric Association.
- World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
- Murray CJL, Ezzati M, Flaxman A, Lim S, Lozano R, et al. (2012) GBD 2010: design, definitions, and metrics. Lancet 380: 2063–2066. 10.1016/S0140-6736(12)61899-6
- Ferrari AJ, Charlson FJ, Norman R, Flaxman AD, Patten SB, et al. (2013) The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PLOS One 8: e69637 10.1371/journal.pone.0069637
- Erskine HE, Ferrari AJ, Nelson P, Polanczyk GV, Flaxman AD, et al. (2013) Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. Journal of Child Psychology and Psychiatry 54: 1263–1274. 10.1111/jcpp.12144
- Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLOS Medicine 2: e141
- Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. British Medical Journal 346 10.1136/bmj.f4242
- Crump C, Winkleby MA, Sundquist K, Sundquist J (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. American Journal of Psychiatry 170: 324–333. 10.1176/appi.ajp.2012.12050599
- Diop AG, Hesdorffer DC, Logroscino G, Hauser WA (2005) Epilepsy and mortality in Africa: a review of the literature. Epilepsia 46: 33–35.
- Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE, et al. (2014) The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the global burden of disease study 2010. PLOS One 9: e91936 10.1371/journal.pone.0091936
- Murray CJ, Acharya AK (1997) Understanding DALYs. Journal of Health Economics 16: 703–730.
- United Nations (2011) World Population Prospects—The 2010 Revision. New York: United Nations; 10.4414/smw.2014.14059
Source: PubMed